These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 7996716)

  • 21. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan determined by the broth microdilution and disk diffusion methods.
    Liao CH; Kung HC; Hsu GJ; Lu PL; Liu YC; Chen CM; Lee CM; Sun W; Jang TN; Chiang PC; Cheng YJ; Lin HC; Shi ZY; Wang LS; Chuang YC; Tsao SM; Lu CT; Liu JW; Huang CH; Hsueh PR
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S192-6. PubMed ID: 19013354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of susceptibility testing methods for polymyxin.
    Behera B; Mathur P; Das A; Kapil A; Gupta B; Bhoi S; Farooque K; Sharma V; Misra MC
    Int J Infect Dis; 2010 Jul; 14(7):e596-601. PubMed ID: 20045367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial susceptibility testing of anaerobic bacteria.
    Sutter VL
    Am J Med Technol; 1976 Apr; 42(4):111-4. PubMed ID: 1266883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of disc breakpoints and evaluation of Etests for tigecycline susceptibility testing by the BSAC method.
    Hope R; Parsons T; Mushtaq S; James D; Livermore DM
    J Antimicrob Chemother; 2007 Oct; 60(4):770-4. PubMed ID: 17704517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Influence of antibiotic disk charge on concordance curve of cefotaxime ].
    Drugeon HB; Seon M; Reynaud A; Chung SS; Courtieu AL
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):517-21. PubMed ID: 6289229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the theory of the disk diffusion test. Evidence for a non-linear relationship between critical concentration and MIC, and its practical implications for susceptibility testing of Haemophilus influenzae.
    Ringertz S; Kronvall G
    APMIS; 1988 Jun; 96(6):484-90. PubMed ID: 3260786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spiral gradient endpoint susceptibility testing: a fresh look at a neglected technique.
    Pong R; Boost MV; O'Donoghue MM; Appelbaum PC
    J Antimicrob Chemother; 2010 Sep; 65(9):1959-63. PubMed ID: 20595209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Triangular comparison of the agar diffusion method, the ABAC system and the Sensitre system for determination of bacterial sensitivity to aminoglycoside chemoantibiotics].
    Sala A; Raffaele L; Cappello P
    Quad Sclavo Diagn; 1981 Mar; 17(1):100-8. PubMed ID: 7313065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regression analyses for cefoperazone on Mueller-Hinton agar and DST agar.
    Langmaack H; Daschner F
    Clin Ther; 1980; 3(Spec Issue):123-6. PubMed ID: 6446384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of an interlaboratory test on antimicrobial susceptibility testing of bacteria from animals by broth microdilution.
    Wallmann J; Böttner A; Goossens L; Hafez HM; Hartmann K; Kaspar H; Kehrenberg C; Kietzmann M; Klarmann D; Klein G; Krabisch P; Kühn T; Luhofer G; Richter A; Schulz B; Schwarz S; Sigge C; Traeder W; Waldmann KH; Werckenthin C; ; Zschiesche E
    Int J Antimicrob Agents; 2006 Jun; 27(6):482-90. PubMed ID: 16697559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Validity of the ABAC II system: applicability in the hospital laboratory and verification of breakpoint concentrations in the determination of antibiotic sensitivity].
    Sala A; Castagna N; Salicetti M; Cappello P; Gandini G
    Quad Sclavo Diagn; 1985 Mar; 21(1):1-9. PubMed ID: 4059508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro study with ciprofloxacin: interpretive criteria of agar diffusion test according to standards of the NCCLS and DIN.
    Grimm H
    Am J Med; 1987 Apr; 82(4A):376-80. PubMed ID: 3578326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical laboratory approach in estimating effective administrative dose of piperacillin. Reevaluation of MIC break points in 3 and 4 category systems of disc susceptibility test].
    Matsuo K; Uete T
    Jpn J Antibiot; 1990 Sep; 43(9):1559-71. PubMed ID: 2262963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical laboratory approach for estimating effective administrative dose of cefoperazone. Evaluation of disc susceptibility test and its interpretation system].
    Matsuo K; Uete T
    Jpn J Antibiot; 1988 Oct; 41(10):1418-29. PubMed ID: 3204655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro susceptibility testing of anaerobic bacteria.
    Washington JA
    Scand J Infect Dis Suppl; 1979; (19):13-6. PubMed ID: 288163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The quantitative expression of susceptibility and its clinical significance].
    Kanno H
    Nihon Rinsho; 1997 May; 55(5):1191-9. PubMed ID: 9155174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical laboratory approach for estimating the effective administrative dose of latamoxef. Significance of a 4-category system interpretation of the latamoxef disc susceptibility test].
    Uete T; Matsuo K
    Jpn J Antibiot; 1987 Nov; 40(11):1906-16. PubMed ID: 3327966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical laboratory approach for estimating effective administrative dose of ceftizoxime. Observation from MIC and ceftizoxime disc susceptibility test].
    Uete T; Matsuo K
    Jpn J Antibiot; 1987 Feb; 40(2):331-9. PubMed ID: 3474430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of a modified Kirby-Bauer disk diffusion method for metronidazole susceptibility testing of Helicobacter pylori.
    Midolo PD; Turnidge J; Lambert JR; Bell JM
    Diagn Microbiol Infect Dis; 1995 Mar; 21(3):135-40. PubMed ID: 7648834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical laboratory approach for estimating effective administrative dose of cephalothin. Reevaluation of MIC break points in 4 category system of disc susceptibility test].
    Uete T; Matsuo K
    Jpn J Antibiot; 1989 Sep; 42(9):1900-12. PubMed ID: 2810753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.